Advanced search
Search:  

1 - 10 of 40 results found for CYCS. Did you mean: ccs

  1. Plasma and cerebrospinal fluid (CSE) pharmacokinetics of cyclophosphamide (CYC) in...

    http://iris.ucl.ac.uk/iris/publication/975258/7

  2. Tucking RCC in cyc's ontological bed

    Formalisms and axiomatic theories are designed to support reasoning, they are often intended with a preferred interpretation and a targeted ontology. Questions of proper interpretations and of the possible challenge of an intended interpretation

    http://iris.ucl.ac.uk/iris/publication/1505845/7

  3. Bartlett Academission builds stronger bridges on recent visit to...

    CYC – Dr Chang Chen-Yu, senior lecturer, Bartlett School of Construction and Project Management. ... AP, CMc, DC, AE, FW, CYC. Symposium:  30 October . Venue: Tongji University, 18.30-20.30.

    https://www.ucl.ac.uk/bartlett/news/2018/jan
    /bartlett-academission-builds-stronger-bridges-recent-visit-china

  4. Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl...

    Ten patients with brain tumors and indwelling ventricular reservoirs were pretreated with 5% to 10% dimethyl sulfoxide (DMSO) (intravenous, oral, or both) and were then treated with 1.0 to 1.25 gm/m cyclophosphamide (CYC). All patients were also on

    http://iris.ucl.ac.uk/iris/publication/975296/7

  5. Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis...

    In patients with severe or refractory juvenile dermatomyositis (JDM), second-line treatments may be required. Cyclophosphamide (CYC) is used to treat some connective tissue diseases, but evidence of efficacy in JDM is limited. This study aimed to

    http://iris.ucl.ac.uk/iris/publication/1527955/1

  6. Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood...

    OBJECTIVE: Cyclophosphamide (CYC) is used in clinical practice off-label for induction of remission of childhood polyarteritis nodosa (cPAN). Mycophenolate mofetil (MMF) might offer a less toxic alternative: we explored their relative effectiveness

    http://iris.ucl.ac.uk/iris/publication/1855630/1

  7. Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated...

    OBJECTIVE: To review the development, histological type and outcome of a cohort of patients with lupus nephritis who were managed and followed up by the specialist Bloomsbury Rheumatology Unit between 1977 and 1999. PATIENTS AND METHODS:

    http://iris.ucl.ac.uk/iris/publication/25931/1

  8. Drosophila CRYPTOCHROME is a circadian transcriptional repressor.

    BACKGROUND: Although most circadian clock components are conserved between Drosophila and mammals, the roles assigned to the CRYPTOCHROME (CRY) proteins are very different: Drosophila CRY functions as a circadian photoreceptor, whereas mammalian CRY

    http://iris.ucl.ac.uk/iris/publication/950104/2

  9. New treatment strategies for proliferative lupus nephritis: keep children in mind!

    Renal involvement is frequent in children with systemic lupus erythematosus (SLE) and carries significant short and long-term morbidity. Treatment strategy in proliferative glomerulonephritis relies mainly on studies in adult patients where

    http://iris.ucl.ac.uk/iris/publication/170693/2

  10. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to...

    Kaposi's sarcoma-associated herpesvirus (KSHV or human herpesvirus 8) is a novel gammaherpesvirus implicated in the cause of Kaposi's sarcoma and certain malignancies of lymphatic origin. One of the candidate genes possibly involved in promoting

    http://iris.ucl.ac.uk/iris/publication/207770/2

  11. Page: 1 2 3 4